Scholars Central

Conference abstractPublished 29 Sep 2014

The immunoregulatory axis of tBregs in cancer escape and metastasis

Authors: Arya Biragyn

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recently we found a new subset of regulatory B cells, designated tumor-evoked Bregs (tBregs), which is generated in response to cancer-produced 5-lipoxygenase metabolites by targeting PPAR α in resting B cells. The role of tBregs is to convert CD4+ T cells into FoxP3+ Treg cells and thereby protect metastasizing cancer cells through the inactivation of effector NK cells and CD8+ T cells. tBregs also activate immunoregulatory functions of MDSCs needed for suppression of antitumor effector cells and metastasis. In the absence of tBregs, metastasis cannot be established despite expansion of MDSCs. Thus, inactivation of tBregs or the blockage of any step of its immunoregulatory axis will provide anti-metastatic benefits. We show that the depletion of Tregs and tBregs by targeting their surface-expressed CD25 abrogates breast cancer lung metastasis in mice, although some strategies, such as the use of B-cell depleting anti-CD20 antibody, can instead be harmful and greatly enhance metastasis due to depletion of beneficial B cells and enrichment of CD20Low tBregs. The regulatory axis can also be blocked using modified chemokines to deliver siRNA or immunostimulatory CpG-ODN to tBregs and Tregs. For example, transient inactivation of FoxP3 or IL-10 in Tregs via siRNA delivered by CCL17 and, alternatively, inactivation of tBregs with CpG-ODN bound CXCL13 can efficiently abrogate metastasis. Overall, our data underscores the importance of tBregs as key initiators of immunoregulatory events needed for successful breast cancer metastasis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Arya Biragyn”